Yes, NABI is experiencing one of the larger one-day drops in recent memory. It's lost about 2/3 of its market cap in premarket. I had always thought it had a decent shot at StaphVax approval, but the price was always too steep for me. This sure has been one stomach-churning year for bios.
Market Data 
Markets 
AI
